1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Regulation

US FDA: 510(k)-Exempt Class II Devices Should Withdraw Applications

In line with the 21st Century Cures Act, US FDA has finalized a list of class II devices that will no longer need pre-market notification to get to market. Also, check out our updated Cures Act implementation table.

Sponsors of products on a final list of class II devices that are now exempt from 510(k) submissions should withdraw any submitted application, says US FDA. Complying with the 21st Century Cures Act passed last year, the agency has finalized a list of devices that will no longer need pre-market notification starting July 11.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation